Thus, reports on AD typically show increased levels of clusterin around amyloid plaques in the brain, plasma/serum, and CSF, although no studies have investigated the different tissues in the same subject, and contradictory findings exist. The gene discussed is CLU; the disease is Alzheimer disease.